CD40 and neoplasm: The administration of Delta-24-RGD and anti-CD40 was able to initially control tumor growth in Batf3ko mice lacking cross-presenting DCs (type 1 conventional dendritic cell [cDC1]), similar to the wild-type mice (Figures S3A and S3B).